Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML
This study is testing a new treatment combination called RAVEN, which includes revumenib, azacitidine, and venetoclax, in patients who are newly diagnosed with…
Leukemia Acute Myeloid
Estimated
~$10 – $6,250
UNC Lineberger Comprehensive Cancer CenterNCT07605949
Phase 1
A Phase 1 Study of BAL0891 as Monotherapy and in Combination With Chemotherapy or Tislelizumab in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
This study is a multiple cohort, multicenter, open-label Phase 1 study with dose-escalation substudies investigating intravenous (IV) BAL0891 as monotherapy, a…
Advanced Solid TumorTNBC - Triple-Negative Breast CancerGastric Cancer+1 more
Estimated
~$10 – $8,750
SillaJen, Inc.NCT05768932